Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Olodaterol Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Boehringer Ingelheim opens inhaler plant with 200 jobs
    Boehringer Ingelheim opens inhaler plant with 200 jobs

    18 Jun 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/boehringer-ingelheim-opens-inhaler-plant-200-jobs

    Eric Palmer FIERCE PHARMA
    18 Jun 2019
    Share Share
    Olodaterol - List of nationally authorised medicinal products in Europe
    Olodaterol - List of nationally authorised medicinal products in Europe

    25 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/psusa-products/olodaterol-list-nationally-authorised-medicinal-products-psusa/00010245/201803_en.pdf

    EMA
    25 Oct 2018
    Share Share
    FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction
    FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction

    11 Oct 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-stiolto-respimat-supplemental-new-drug-application-snda-to-add-data-on-copd-exacerbation-reduction-300729059.html

    PR NEWSWIRE
    11 Oct 2018
    Share Share
    FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction
    FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction

    11 Oct 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-stiolto-respimat-supplemental-new-drug-application-snda-to-add-data-on-copd-exacerbation-reduction-300729059.html

    PR NEWSWIRE
    11 Oct 2018
    Share Share
    FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction
    FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD Exacerbation Reduction

    11 Oct 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-stiolto-respimat-supplemental-new-drug-application-snda-to-add-data-on-copd-exacerbation-reduction-300729059.html

    PR NEWSWIRE
    11 Oct 2018
    Share Share
    Boehringer Ingelheim announces study results of Spiolto Respimat trial
    Boehringer Ingelheim announces study results of Spiolto Respimat trial

    17 Sep 2018

    // James Ives MEDICAL NEWS

    https://www.news-medical.net/news/20180917/Boehringer-Ingelheim-announces-study-results-of-COPD-patients-treated-with-Spiolto-Respimat.aspx

    James Ives MEDICAL NEWS
    17 Sep 2018
    Share Share